免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Comparison of Two Extubation Techniques in Critically Ill Adult Patients (ExtubAR)

Comparison of Two Extubation Techniques in Critically Ill Adult Patients (ExtubAR)

Study Description
Brief Summary:

Orotracheal extubation consists in the removal of the endotracheal tube (ETT) when it is no longer required. This procedure may carry a considerable risk of complications and extubation failure. The literature points out two methods of extubation: the traditional method and the positive pressure method.

In a noninferiority clinical trial it was demonstrated that EOT with positive pressure and without endotracheal suction was a safe technique and could be better than traditional extubation. Although prior studies reported better clinical outcomes with the positive pressure extubation technique, its superiority has not been deeply studied yet. Therefore, the objective of our study is to determine whether the positive pressure OTE technique, compared with the traditional OTE technique, reduces the incidence of major postextubation complications (up to 60 minutes) in critically ill adult patients.


Condition or disease Intervention/treatment Phase
Weaning Failure Mechanical Ventilation Complication Procedure: Positive Pressure Extubation Technique Procedure: Traditional Extubation Technique Not Applicable

Detailed Description:

Design: Multicenter randomized controlled clinical trial Methods: Critically ill adult subjects on invasive mechanical ventilation who met extubation criteria will be included. Will be randomly assigned to positive-pressure extubation (n=389) or to traditional extubation (n=389).

The main variable will be incidence of major complications.

Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 725 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: superiority
Masking: Double (Investigator, Outcomes Assessor)
Masking Description: Due to the nature of the intervention, blinding of the subject and the operators responsible for extubation is not possible. The person in charge of data statistical analysis and the evaluator who assess and record outcome measures will be blinded to the allocated intervention.
Primary Purpose: Treatment
Official Title: Comparison of Two Extubation Techniques in Critically Ill Adult Patients (ExtubAR Trial): Randomized Clinical Trial
Actual Study Start Date : April 1, 2019
Actual Primary Completion Date : March 26, 2020
Actual Study Completion Date : March 26, 2020
Arms and Interventions
Arm Intervention/treatment
Experimental: Positive Pressure Extubation Technique
ETT is removed in PSV 15/10 mode and without endotracheal suction.
Procedure: Positive Pressure Extubation Technique
Positive-pressure extubation is performed by only one operator. Ventilator parameters are set to pressure support ventilation mode, with an inspiratory pressure of 15 cm H2O and PEEP of 10 cm H2O. Then, the cuff is deflated, and the ETT is removed without endotracheal suction. Once the ETT is removed, a suction catheter is introduced through the mouth to suction secretions drawn to the oropharynx by the air flow from the ventilator passing between the ETT and the larynx.

Active Comparator: Traditional Extubation Technique
ETT is removed with continuous endotracheal suction
Procedure: Traditional Extubation Technique
Traditional extubation is performed by 2 operators. Without reconnection to the ventilator, the closed suction system catheter is introduced by one of the operators into the ETT and suctioning is initiated. The cuff is immediately deflated by the other operator, and the ETT is removed with continuous endotracheal suction during the whole procedure by the first operator.

Outcome Measures
Primary Outcome Measures :
  1. Number of Participants With Major Post Extubation Complications [ Time Frame: Within15 minutes after extubation. ]

    Clinical evidence of at least one of the following:

    • Upper airway obstruction
    • Desaturation
    • Vomiting


Secondary Outcome Measures :
  1. Number of Participants With Minor Post Extubation Complications [ Time Frame: Hypertension, Tachycardia, Tachypnea or Poor Respiratory Mechanics, within 15 minutes after extubation. Bronchospasm, Severe cough or Post Obstructive Pulmonary Edema, within 60 minutes after extubation. ]

    Clinical evidence of at least one of the following:

    • Hypertension
    • Tachycardia
    • Tachypnea
    • Poor respiratory mechanics
    • Bronchospasm
    • Severe cough
    • Post obstructive pulmonary edema

  2. Number of Participants With Overall Post Extubation Complications [ Time Frame: Upper airway obstruction, Desaturation, Vomiting, Hypertension, Tachycardia, Tachypnea, Poor Respiratory Mechanics, within 15 minutes after extubation. Bronchospasm, Severe cough or Post Obstructive Pulmonary Edema, within 60 minutes after extubation. ]

    Clinical evidence of at least one of the following:

    • Upper airway obstruction
    • Desaturation
    • Vomiting
    • Hypertension
    • Tachycardia
    • Tachypnea
    • Poor respiratory mechanics
    • Bronchospasm
    • Severe cough
    • Post obstructive pulmonary edema

  3. Number of Participants With Post Extubation Pneumonia [ Time Frame: Within 72 hours after extubation. ]
    Presence of a new radiographic infiltrate or progression of infiltrates prior to extubation and any of the following: fever, leukocytosis (greater than 10,000 / mm3) or leukopenia (less than 4,000 / mm3) compared to the value prior to extubation and increase in the amount or change in the quality of tracheobronchial secretions.

  4. Number of Participants With Extubation Failure [ Time Frame: Within 72 hours after extubation. ]
    Use of Non Invasive Ventilation to treat the failure or need of reintubation.

  5. Number of Participants That Required Reintubation [ Time Frame: Within 72 hours after extubation. ]
    Need of reintubation.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age >18
  • Invasive mechanical ventilation through an endotracheal tube,
  • Successfully complete a spontaneous breathing trial
  • Adequate level of consciousness (Glasgow Coma Score >8)
  • Effective cough.
  • Written informed consent from a relative or legal representative.

Exclusion Criteria:

  • History of upper airway injury or surgery
  • Previously extubated or tracheostomized
  • Noninvasive ventilation (NIV) as a weaning method
  • Decision to not reanimate
Contacts and Locations

Locations
Layout table for location information
Argentina
Hospital Santojanni
Buenos Aires, Argentina, 1408
Sponsors and Collaborators
Hospital Donación Francisco Santojanni
Matías Bertozzi
Marco Bezzi
Silvina Borello
Daniela Castro
Victoria Di Giorgio
Mariana Aguirre
Karina Miralles
Diego Noval
Sebastián Fredes
Eliana Wilhelm
Mauricio Zakimchuk
Julián Buffarini Cignoli
Mariana Bernardini
Leticia Rey
Valeria Pieroni
Pablo D´Annunzio
Gustavo Plotnikow
Romina Prato
Matías Lompizano
María Guaymas
Matías Accoce
Javier Dorado
Gimena Cardoso
Patricia Torres
Vanesa Pavlotsky
Emiliano Navarro
Eliana Markman
Paula Di Nardo
Ivonne Kunzi Steyer
Carolina Thomsen
Cecilia Palacios
Mariela Davies
Mercedes Ruffo
Victoria Leon
Fernando Tapia
Investigators
Layout table for investigator information
Principal Investigator: Mauro F Andreu, Prof Hospital Santojanni
Tracking Information
First Submitted Date  ICMJE April 14, 2019
First Posted Date  ICMJE April 18, 2019
Results First Submitted Date  ICMJE December 28, 2020
Results First Posted Date  ICMJE February 9, 2021
Last Update Posted Date February 9, 2021
Actual Study Start Date  ICMJE April 1, 2019
Actual Primary Completion Date March 26, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: January 20, 2021)
Number of Participants With Major Post Extubation Complications [ Time Frame: Within15 minutes after extubation. ]
Clinical evidence of at least one of the following:
  • Upper airway obstruction
  • Desaturation
  • Vomiting
Original Primary Outcome Measures  ICMJE
 (submitted: April 16, 2019)
Incidence of post extubation major complication [ Time Frame: Within15 minutes after extubation. ]
Clinical evidence of at least one of the following:
  • Upper airway obstruction
  • Desaturation
  • Vomiting
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: January 20, 2021)
  • Number of Participants With Minor Post Extubation Complications [ Time Frame: Hypertension, Tachycardia, Tachypnea or Poor Respiratory Mechanics, within 15 minutes after extubation. Bronchospasm, Severe cough or Post Obstructive Pulmonary Edema, within 60 minutes after extubation. ]
    Clinical evidence of at least one of the following:
    • Hypertension
    • Tachycardia
    • Tachypnea
    • Poor respiratory mechanics
    • Bronchospasm
    • Severe cough
    • Post obstructive pulmonary edema
  • Number of Participants With Overall Post Extubation Complications [ Time Frame: Upper airway obstruction, Desaturation, Vomiting, Hypertension, Tachycardia, Tachypnea, Poor Respiratory Mechanics, within 15 minutes after extubation. Bronchospasm, Severe cough or Post Obstructive Pulmonary Edema, within 60 minutes after extubation. ]
    Clinical evidence of at least one of the following:
    • Upper airway obstruction
    • Desaturation
    • Vomiting
    • Hypertension
    • Tachycardia
    • Tachypnea
    • Poor respiratory mechanics
    • Bronchospasm
    • Severe cough
    • Post obstructive pulmonary edema
  • Number of Participants With Post Extubation Pneumonia [ Time Frame: Within 72 hours after extubation. ]
    Presence of a new radiographic infiltrate or progression of infiltrates prior to extubation and any of the following: fever, leukocytosis (greater than 10,000 / mm3) or leukopenia (less than 4,000 / mm3) compared to the value prior to extubation and increase in the amount or change in the quality of tracheobronchial secretions.
  • Number of Participants With Extubation Failure [ Time Frame: Within 72 hours after extubation. ]
    Use of Non Invasive Ventilation to treat the failure or need of reintubation.
  • Number of Participants That Required Reintubation [ Time Frame: Within 72 hours after extubation. ]
    Need of reintubation.
Original Secondary Outcome Measures  ICMJE
 (submitted: April 16, 2019)
  • Incidence of post extubation minor complication [ Time Frame: Hypertension, Tachycardia, Tachypnea or Poor Respiratory Mechanics, within 15 minutes after extubation. Bronchospasm, Severe cough or Post Obstructive Pulmonary Edema, within 60 minutes after extubation. ]
    Clinical evidence of at least one of the following:
    • Hypertension
    • Tachycardia
    • Tachypnea
    • Poor respiratory mechanics
    • Bronchospasm
    • Severe cough
    • Post obstructive pulmonary edema
  • Incidence of post extubation overall complication [ Time Frame: Upper airway obstruction, Desaturation, Vomiting, Hypertension, Tachycardia, Tachypnea, Poor Respiratory Mechanics, within 15 minutes after extubation. Bronchospasm, Severe cough or Post Obstructive Pulmonary Edema, within 60 minutes after extubation. ]
    Clinical evidence of at least one of the following:
    • Upper airway obstruction
    • Desaturation
    • Vomiting
    • Hypertension
    • Tachycardia
    • Tachypnea
    • Poor respiratory mechanics
    • Bronchospasm
    • Severe cough
    • Post obstructive pulmonary edema
  • Incidence of post extubation Pneumonia [ Time Frame: Within 72 hours after extubation. ]
    Presence of a new radiographic infiltrate or progression of infiltrates prior to extubation and any of the following: fever, leukocytosis (greater than 10,000 / mm3) or leukopenia (less than 4,000 / mm3) compared to the value prior to extubation and increase in the amount or change in the quality of tracheobronchial secretions.
  • Incidence of Extubation failure [ Time Frame: Within 72 hours after extubation. ]
    Use of Non Invasive Ventilation to treat the failure or need of reintubation.
  • Incidence of Reintubation [ Time Frame: Within 72 hours after extubation. ]
    Need of reintubation.
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Comparison of Two Extubation Techniques in Critically Ill Adult Patients
Official Title  ICMJE Comparison of Two Extubation Techniques in Critically Ill Adult Patients (ExtubAR Trial): Randomized Clinical Trial
Brief Summary

Orotracheal extubation consists in the removal of the endotracheal tube (ETT) when it is no longer required. This procedure may carry a considerable risk of complications and extubation failure. The literature points out two methods of extubation: the traditional method and the positive pressure method.

In a noninferiority clinical trial it was demonstrated that EOT with positive pressure and without endotracheal suction was a safe technique and could be better than traditional extubation. Although prior studies reported better clinical outcomes with the positive pressure extubation technique, its superiority has not been deeply studied yet. Therefore, the objective of our study is to determine whether the positive pressure OTE technique, compared with the traditional OTE technique, reduces the incidence of major postextubation complications (up to 60 minutes) in critically ill adult patients.

Detailed Description

Design: Multicenter randomized controlled clinical trial Methods: Critically ill adult subjects on invasive mechanical ventilation who met extubation criteria will be included. Will be randomly assigned to positive-pressure extubation (n=389) or to traditional extubation (n=389).

The main variable will be incidence of major complications.

Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
superiority
Masking: Double (Investigator, Outcomes Assessor)
Masking Description:
Due to the nature of the intervention, blinding of the subject and the operators responsible for extubation is not possible. The person in charge of data statistical analysis and the evaluator who assess and record outcome measures will be blinded to the allocated intervention.
Primary Purpose: Treatment
Condition  ICMJE
  • Weaning Failure
  • Mechanical Ventilation Complication
Intervention  ICMJE
  • Procedure: Positive Pressure Extubation Technique
    Positive-pressure extubation is performed by only one operator. Ventilator parameters are set to pressure support ventilation mode, with an inspiratory pressure of 15 cm H2O and PEEP of 10 cm H2O. Then, the cuff is deflated, and the ETT is removed without endotracheal suction. Once the ETT is removed, a suction catheter is introduced through the mouth to suction secretions drawn to the oropharynx by the air flow from the ventilator passing between the ETT and the larynx.
  • Procedure: Traditional Extubation Technique
    Traditional extubation is performed by 2 operators. Without reconnection to the ventilator, the closed suction system catheter is introduced by one of the operators into the ETT and suctioning is initiated. The cuff is immediately deflated by the other operator, and the ETT is removed with continuous endotracheal suction during the whole procedure by the first operator.
Study Arms  ICMJE
  • Experimental: Positive Pressure Extubation Technique
    ETT is removed in PSV 15/10 mode and without endotracheal suction.
    Intervention: Procedure: Positive Pressure Extubation Technique
  • Active Comparator: Traditional Extubation Technique
    ETT is removed with continuous endotracheal suction
    Intervention: Procedure: Traditional Extubation Technique
Publications *
  • Andreu MF, Salvati IG, Donnianni MC, Ibañez B, Cotignola M, Bezzi M. Effect of applying positive pressure with or without endotracheal suctioning during extubation: a laboratory study. Respir Care. 2014 Dec;59(12):1905-11. doi: 10.4187/respcare.03121. Epub 2014 Nov 25.
  • Andreu MF, Dotta ME, Bezzi MG, Borello S, Cardoso GP, Dib PC, García Schustereder SL, Galloli AM, Castro DR, Di Giorgio VL, Villalba FJ, Bertozzi MN, Carballo JM, Martín MC, Brovia CC, Pita MC, Pedace MP, De Benedetto MF, Delli Carpini J, Aguirre P, Montero G. Safety of Positive Pressure Extubation Technique. Respir Care. 2019 Aug;64(8):899-907. doi: 10.4187/respcare.06541. Epub 2019 Mar 26.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Terminated
Actual Enrollment  ICMJE
 (submitted: January 20, 2021)
725
Original Estimated Enrollment  ICMJE
 (submitted: April 16, 2019)
778
Actual Study Completion Date  ICMJE March 26, 2020
Actual Primary Completion Date March 26, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Age >18
  • Invasive mechanical ventilation through an endotracheal tube,
  • Successfully complete a spontaneous breathing trial
  • Adequate level of consciousness (Glasgow Coma Score >8)
  • Effective cough.
  • Written informed consent from a relative or legal representative.

Exclusion Criteria:

  • History of upper airway injury or surgery
  • Previously extubated or tracheostomized
  • Noninvasive ventilation (NIV) as a weaning method
  • Decision to not reanimate
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Argentina
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03918811
Other Study ID Numbers  ICMJE 12-2018-05
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Mauro Andreu, Hospital Donación Francisco Santojanni
Study Sponsor  ICMJE Hospital Donación Francisco Santojanni
Collaborators  ICMJE
  • Matías Bertozzi
  • Marco Bezzi
  • Silvina Borello
  • Daniela Castro
  • Victoria Di Giorgio
  • Mariana Aguirre
  • Karina Miralles
  • Diego Noval
  • Sebastián Fredes
  • Eliana Wilhelm
  • Mauricio Zakimchuk
  • Julián Buffarini Cignoli
  • Mariana Bernardini
  • Leticia Rey
  • Valeria Pieroni
  • Pablo D´Annunzio
  • Gustavo Plotnikow
  • Romina Prato
  • Matías Lompizano
  • María Guaymas
  • Matías Accoce
  • Javier Dorado
  • Gimena Cardoso
  • Patricia Torres
  • Vanesa Pavlotsky
  • Emiliano Navarro
  • Eliana Markman
  • Paula Di Nardo
  • Ivonne Kunzi Steyer
  • Carolina Thomsen
  • Cecilia Palacios
  • Mariela Davies
  • Mercedes Ruffo
  • Victoria Leon
  • Fernando Tapia
Investigators  ICMJE
Principal Investigator: Mauro F Andreu, Prof Hospital Santojanni
PRS Account Hospital Donación Francisco Santojanni
Verification Date January 2021

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP